Ever Source Wealth Advisors, LLC Erasca, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 2,442 shares of ERAS stock, worth $6,007. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,442
Previous 1,515
61.19%
Holding current value
$6,007
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ERAS
# of Institutions
151Shares Held
217MCall Options Held
258KPut Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA22.7MShares$55.9 Million1.52% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD20.3MShares$50 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY17.9MShares$43.9 Million4.49% of portfolio
-
Logos Global Management LP San Francisco, CA15MShares$36.9 Million2.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.5MShares$35.7 Million0.63% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $300M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...